Role of insulin-like growth factor-I in esophageal mucosal healing processes

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 2, 1998, Pages 134-141

  Tchorzewski, M T ^b   Qureshi, F G ^b   Duncan, M D ^b   Duncan, K L K ^b   Saini, N ^b   Harmon, J W ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032146677     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90008-7     Document Type: Article

References (43)

1. Nowak R. A new test gives early warning of a growing killer. Science 1994;264:1847-8.
2. Read LC, Lemmey AB, Howarth GS, Martin AA, Tomas FM, Ballard FJ. The gastrointestinal tract is one of the most responsive target tissues of IGF-I and its potent analogs. In: Spencer EM, editor. Modern concepts of insulin-like growth factors. Amsterdam: Elsevier, 1991.
3. Chaurasia OP, Marcuard SP, Seidel ER. Insulin-like growth factor in gastrointestinal exocrine secretions. Regul Pept 1994;50:113-9.
4. Bennett NT, Shultz GS. Growth factors in wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
5. Bennett NT, Shultz GS. Growth factors in wound healing: part II. Role in normal and chronic wound healing. Am J Surg 1993;166:74-81.
6. Costigan DC, Harvey JD, Posner BI. Free insulin-like factor (IGF-I) and IGF-II in human saliva. J Clin Endocrinol Metab 1988;66:1014-8.
7. Lipkin M. Proliferation and differentiation of normal and diseased gastrointestinal cells. Physiol Gastrointest Tract 1987;1:255.
8. Steeb CB, Trahair JF, Tomas FM, Read LC. Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 1994;266:G1090-8.
9. Lund PK, Moats-Staats MA, Simmons JG, Jansen M, D'Ercole AJ, VanWyk JJ. Somatomedin C/insulin-like growth factor I and insulin-like growth factor II and their relationship to the insulin receptor. J Biol Chem 1986;261:14539.
10. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: further evidence of multiple sites of synthesis and paracrine and autocrine mechanisms of action. Proc Natl Acad Sci USA 1984;81:935-9.
11. Donovan SM, Oh Y, Pham H, Rosenfeld RG. Ontogeny of serum insulin-like growth factor I binding proteins in the rat. Endocrinology 1989;125:2621-7.
12. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70:591-614.
13. Ryan J, Mantle T, McQuaid S, Costigan DC. Salivary insulin-like growth factor I originates from local synthesis. J Endocrinol 1992;135:85-90.
14. Olsen PS, Poulsen SS, Kirkegaard P, Nexo E. Role of Sub-mandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 1984;87:103-8.
15. Jyung RW, Mustoe TA, Busby WH, Clemmons DR. Increased wound-breaking strength induced by insulin-like growth factor in combination with IGF-I binding protein-1. Surgery 1994;115:233-9.
16. DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock 1995;4:233-40.
17. Vinayek R, Picheny LS, Tantry U, Dutta SK, Resau J, Vengurlekar S. Characterization of insulin-like growth factor I receptors in human esophageal epithelial cells. Am J Physiol 1994;267:G105-14.
18. Termanini B, Nardi RV, Finan TM, Parikh I, Korman LY. Insulin-like growth factor in rabbit gastrointestinal tract. Gastroenterology 1990;99:51-60.
19. Laburthe M, Rouyer-Fessard C, Gammeltoft S. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am J Physiol 1988;254:G457-62.
20. Yarden Y, Ullrich A. Growth factors tyrosine kinases. Am Rev Biochem 1988;57:443-78.
21. Levitzki A, Gilon C. Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol Sci 1991;12:171-4.
22. Levitzki A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J 1992;6:3275-82.
23. Gazit A, Osherov N, Posner I, Yaish P, Poraadosu E, Gilon C, et al. Tyrphostins. Two heterocyclic and α-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and erbB2/neu tyrosine kinases. J Med Chem 1991;34:1896-907.
24. Yaish P, Gazit A, Gilon C, Levitzki A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 1988;242:933-5.
25. Resau JH, Cottrell JR, Elligett KA, Hudson EA. Cell injury and regeneration of human epithelium in organ culture. Cell Biol Toxicol 1987;3:441-58.
26. Berthet B, Di Costanzo J, Arnaud C, Choux R, Assadourian R. Influence of epidermal growth factor and Interferon on healing of oesophageal corrosive burns in the rat. Br J Surg 1994;81:395-8.
27. Jankowski J, Coghill G, Tregaskis B, Hopwood D, Wormsley KG. Epidermal growth factor in the oesophagus. Gut 1992;33:1448-53.
28. Kato H, Faria TN, Stannard B, Roberts CT, LeRoith D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor. J Biol Chem 1993;268:2655-61.
29. Sion-Vardy N, Vardy D, Rodeck U, Kari C, Levin RM, Malkovicz BS. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma. J Surg Res 1995;59:675-80.
30. Huffman R, Dennis IF, Donaldson J. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins. Cancer Chem Pharmacol 1995;36:316-24.
31. Gillepsie J, Dye JF, Schachter M, Guillou PJ. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors. Br J Cancer 1993;68:1122-6.
32. Duncan MD, Korman LY, Bass BL. Epithelial growth factor primes intestinal epithelial cells proliferative effect of insulin-like growth factor I. Dig Dis Sci 1994;39:2197-201.
33. Dunkin BJ, HamdyA, Bhora F, McKie LD, Harmon JW, Bass BL. Epidermal growth factor is a potent stimulus to esophageal mucosal growth. Surg Forum 1994;45:120.
34. O'Keefe EJ, Pledger WJ. A model of cell cycle control: sequential events regulated by growth factors. Mol Cell Endocrinol 1983;31:167-86.
35. Mandai S, Shivapurkar NM, Galati AJ, Stoner GD. Inhibition of N-nitrosobenzylmethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid. Carcinogenesis 1988;9:1313-6.
36. Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, et al. Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 1995;59:236-44.
37. Parrizas M, Gazit A, Levitski A, Wertheimer E, LeRoith D. Specific inhibition of insulin-like growth factor-I and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 1997;138:1427-33.
38. Hughes AD, Patel M, Wijetunge S, Clunn G, Schachter M. Comparison of effects of platelet-derived growth factor iso-forms on signaling and DNA synthesis of human cultured saphenous vein cells. J Cardiovasc Pharmacol 1995;25:481-5.
39. Balbaa M, Honke K, Makita A. Regulation of glycolipid sulgotransferase by tyrosine kinases in human renal cancer cells. Biochim Biophys Acta 1995;1299:141-5.
40. Suzuki K, Tsukatani Y, Takahashi K. Inhibition of demecolin-induced DNA synthesis by inhibitors of phospholipase C and protein kinase C. Biochim Biophys Res Commun 1996;219:163-7.
41. Mollerup S, Haugen A. Differential effect of polyansaturated fatty acids on cell proliferation during human epithelial in vitro carcinogenesis: involvement of epidermal growth factor receptor tyrosine kinase. Br J Cancer 1996;74:613-8.
42. Touyz RM, Schiffrin EL. Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium transients in vascular smooth muscle cells. Hypertension 1996;27:1097-103.
43. Qureshi FG, Tchorzewski MT, Duncan MD, Harmon JW. EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells. J Surg Res 1997;69:354-8.